MedPath

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

Not Applicable
Completed
Conditions
Anesthesia
Interventions
Registration Number
NCT05507476
Lead Sponsor
Zagazig University
Brief Summary

Dacryocystorhinostomy aims to create a channel between the lacrimal sac and nasal mucosa to relieve nasolacrimal duct occlusion. General anesthesia is still preferred by many surgeons to secure the airway and control blood pressure.

Detailed Description

Bleeding even minor can obscure the surgical field. This can extend the operative time \& increase the failure rate. The hemostatic effect of desmopressin on the quality of the surgical field was investigated in patients undergoing endoscopic sinus surgery and revealed that desmopressin could reduce intraoperative bleeding.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Age: 18-45 years old.
  • Physical status: ASA I & II.
  • Type of operations: elective endonasal dacryocystorhinostomy under general anesthesia.
  • Written informed consent from the patient.
Exclusion Criteria
  • Patient refusal.
  • Known hypersensitivity to study drugs.
  • Nasal pathology as active infection or an anatomical abnormality.
  • Hyponatremia "serum Na+ less than 135".
  • Coagulation disorders.
  • Renal or cardiovascular disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Desmopressin groupDesmopressin Acetate Nasal, 10 μg/0.1 ml per sprayThe patient will receive two puffs of desmopressin acetate 10 µg/puff in the side of the nasal cavity ipsilateral to the obstructed lacrimal duct (20 μg totally) 60 minutes before surgery "Minirin 10 μg/0.1 ml per spray, Ferring Pharmaceutical Company". Three normal saline-soaked packs will be placed in the middle meatus for 5 minutes immediately before the start of surgery.
Primary Outcome Measures
NameTimeMethod
Intraoperative blood lossMeasurement will be done at 60th minutes of the start of surgery.

Estimation of intraoperative blood loss will be done at 60th minutes of surgery.

by calculating the loss of blood and irrigation saline in 50 mL-graded suction canisters.

Secondary Outcome Measures
NameTimeMethod
Change in serum sodium levelpreoperative and after 12 hours postoperative

Serum sodium level will be measured pre \& postoperative to detect and manage any sodium disturbances.

Change in heart rate (HR) in beat per minutewill be recorded at 2 minutes, 5 minutes, 10 minutes, 30 minutes and 60 minutes after topical epinephrine packs insertion.

Change in heart rate (HR) from baseline.

The surgeon's satisfactionAt the end of surgery

The surgeon was asked to rate satisfaction at the end of surgery (4 =excellent, 3 = good, 2 = fair, 1 = poor, 0 = extremely poor).

The Surgical field clarityat the end of surgery

The quality of surgical field based on BOEZAART grading system(0 no bleeding; 1 slight bleeding: no suctioning is needed; 2 slight bleeding: occasional suctioning needed;, 3 sight bleeding: frequent suctioning required, bleeding threatens surgical field a few seconds after suction is removed; 4 moderate bleeding: frequent suctioning required and bleeding threatens surgical field directly after suction is removed; 5 severe bleeding: constant suctioning required)

Change mean arterial blood pressure (MAP) in mmHgwill be recorded at 2 minutes, 5 minutes, 10 minutes, 30 minutes and 60 minutes after topical epinephrine packs insertion.

Change mean arterial blood pressure (MAP) from baseline.

Change oxygen saturation (SPO2)will be recorded at 2 minutes, 5 minutes, 10 minutes, 30 minutes and 60 minutes after topical epinephrine packs insertion.

Change oxygen saturation (SPO2) from baseline.

Trial Locations

Locations (1)

Zagazig university hospital

🇪🇬

Zagazig, Al-Sharkia, Egypt

© Copyright 2025. All Rights Reserved by MedPath